We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Jordanian drug manufacturers are looking to boost their global presence,
in the wake of the country's US free trade agreement and WTO accession in 2000.
According to reports in the Indian media, the country's government
is negotiating with two British institutions on developing intellectual property rights.
Biotechnology company Galapagos has declared its bid for UK counterpart Biofocus unconditional. The Belgian-Dutch company yesterday announced that 76.9 percent of Biofocus shares have been tendered.
Orchid Chemicals and Pharmaceuticals recorded a net profit of Rs 27.22 crore in the second quarter of 2005-06, a rise in 587 per cent compared with the Rs 3.96 crore recorded in the corresponding quarter of the previous year.
Medicure Inc. (TSX:MPH)(AMEX:MCU), a cardiovascular drug discovery and development company, today reported the results of operations for the three-month period ended August 31, 2005.
Sterling Biotech Limited, one of the world's largest manufacturers of Pharmaceutical Gelatin, has signed a Memorandum of Understanding (MoU) to purchase the manufacturing facility of Torrent Gujarat Biotech Ltd as an asset sale for Rs 55 crore in all cash deal.
Transgene S.A., Strasbourg, France (Eurolist Paris: FR0005175080) today announced that it has signed a manufacturing agreement with Innogenetics, a biotechnology company located in Gent, Belgium, to produce Innogenetics' clinical-grade Hepatitis B therapeutic vaccine candidate.